BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
Frequently Asked Questions
What is Market Cap of Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) market cap is N/A.
What is the 52-week high for Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) 52 week high is N/A as of October 10, 2025.
What is the 52-week low for Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) 52 week low is N/A as of October 10, 2025.
What is Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) stock price today?
What is the PE ratio of Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)’s P/E ratio is None.
What is the Price-to-Book ratio of Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) P/B ratio is None.
What is Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)'s EBITDA is N/A.
What is the 50-day moving average of Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) 50-day moving average is N/A.
How many employess does Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) has?
Biondvax Pharmaceuticals Ltd - Warrants (15/05/2020) has N/A employees.
